Vivo Capital, LLC Astria Therapeutics, Inc. Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
A detailed history of Vivo Capital, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 1,552,685 shares of ATXS stock, worth $10.3 Million. This represents 1.76% of its overall portfolio holdings.
Number of Shares
1,552,685
Previous 1,552,685
-0.0%
Holding current value
$10.3 Million
Previous $8.29 Million
0.37%
% of portfolio
1.76%
Previous 2.25%
Shares
5 transactions
Others Institutions Holding ATXS
# of Institutions
110Shares Held
49.3MCall Options Held
6.6KPut Options Held
0-
Perceptive Advisors LLC New York, NY6.49MShares$43.1 Million1.53% of portfolio
-
Vestal Point Capital, LP New York, NY4.52MShares$30.1 Million1.28% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.11MShares$27.3 Million6.34% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$23.6 Million5.84% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$23.4 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $101M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...